Neogen ROE 2010-2024 | NEOG
Current and historical return on equity (ROE) values for Neogen (NEOG) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Neogen ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-02-29 | $0.00B | $3.15B | 0.10% |
| 2023-11-30 | $0.01B | $3.15B | 0.41% |
| 2023-08-31 | $-0.03B | $3.15B | -0.83% |
| 2023-05-31 | $-0.02B | $3.13B | -0.90% |
| 2023-02-28 | $-0.01B | $3.13B | -0.70% |
| 2022-11-30 | $-0.02B | $3.11B | -1.18% |
| 2022-08-31 | $0.04B | $0.88B | 4.10% |
| 2022-05-31 | $0.05B | $0.89B | 5.51% |
| 2022-02-28 | $0.05B | $0.88B | 5.70% |
| 2021-11-30 | $0.06B | $0.87B | 6.77% |
| 2021-08-31 | $0.06B | $0.86B | 7.56% |
| 2021-05-31 | $0.06B | $0.84B | 7.68% |
| 2021-02-28 | $0.06B | $0.81B | 7.97% |
| 2020-11-30 | $0.06B | $0.78B | 8.09% |
| 2020-08-31 | $0.06B | $0.75B | 8.33% |
| 2020-05-31 | $0.06B | $0.73B | 8.46% |
| 2020-02-29 | $0.06B | $0.71B | 8.74% |
| 2019-11-30 | $0.06B | $0.69B | 9.20% |
| 2019-08-31 | $0.06B | $0.66B | 9.52% |
| 2019-05-31 | $0.06B | $0.64B | 9.83% |
| 2019-02-28 | $0.06B | $0.62B | 10.49% |
| 2018-11-30 | $0.07B | $0.60B | 11.55% |
| 2018-08-31 | $0.07B | $0.58B | 12.15% |
| 2018-05-31 | $0.06B | $0.56B | 12.13% |
| 2018-02-28 | $0.06B | $0.54B | 11.47% |
| 2017-11-30 | $0.05B | $0.52B | 10.56% |
| 2017-08-31 | $0.05B | $0.49B | 9.75% |
| 2017-05-31 | $0.04B | $0.47B | 9.68% |
| 2017-02-28 | $0.04B | $0.45B | 9.60% |
| 2016-11-30 | $0.04B | $0.44B | 9.49% |
| 2016-08-31 | $0.04B | $0.42B | 9.33% |
| 2016-05-31 | $0.04B | $0.40B | 9.38% |
| 2016-02-29 | $0.04B | $0.39B | 9.44% |
| 2015-11-30 | $0.03B | $0.38B | 9.50% |
| 2015-08-31 | $0.03B | $0.37B | 9.56% |
| 2015-05-31 | $0.03B | $0.35B | 9.90% |
| 2015-02-28 | $0.03B | $0.34B | 9.93% |
| 2014-11-30 | $0.03B | $0.33B | 10.30% |
| 2014-08-31 | $0.03B | $0.32B | 10.02% |
| 2014-05-31 | $0.03B | $0.31B | 10.09% |
| 2014-02-28 | $0.03B | $0.29B | 10.16% |
| 2013-11-30 | $0.03B | $0.28B | 10.60% |
| 2013-08-31 | $0.03B | $0.27B | 11.45% |
| 2013-05-31 | $0.03B | $0.26B | 11.53% |
| 2013-02-28 | $0.03B | $0.25B | 11.59% |
| 2012-11-30 | $0.03B | $0.24B | 11.16% |
| 2012-08-31 | $0.02B | $0.23B | 10.69% |
| 2012-05-31 | $0.02B | $0.22B | 10.62% |
| 2012-02-29 | $0.02B | $0.21B | 11.01% |
| 2011-11-30 | $0.02B | $0.20B | 11.47% |
| 2011-08-31 | $0.02B | $0.20B | 12.50% |
| 2011-05-31 | $0.02B | $0.19B | 13.14% |
| 2011-02-28 | $0.02B | $0.18B | 13.25% |
| 2010-11-30 | $0.02B | $0.17B | 13.29% |
| 2010-08-31 | $0.02B | $0.16B | 13.29% |
| 2010-05-31 | $0.02B | $0.15B | 12.50% |
| 2010-02-28 | $0.02B | $0.15B | 11.59% |
| 2009-11-30 | $0.02B | $0.14B | 11.30% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.591B | $0.822B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.422B | 24.34 |
| Stryker (SYK) | United States | $128.275B | 31.81 |
| Boston Scientific (BSX) | United States | $107.479B | 34.23 |
| Medtronic (MDT) | Ireland | $105.230B | 14.90 |
| EssilorLuxottica (ESLOY) | France | $98.467B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.075B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.356B | 30.00 |
| ResMed (RMD) | United States | $26.979B | 25.30 |
| Terumo (TRUMY) | Japan | $24.775B | 34.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.604B | 15.84 |
| Baxter (BAX) | United States | $20.430B | 14.90 |
| Koninklijke Philips (PHG) | Netherlands | $19.242B | 15.35 |
| Insulet (PODD) | United States | $11.496B | 60.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.440B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.860B | 23.42 |
| BellRing Brands (BRBR) | United States | $7.238B | 38.92 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.452B | 22.77 |
| Perrigo (PRGO) | Ireland | $4.238B | 12.12 |
| GN Store Nord (GNNDY) | Denmark | $3.889B | 25.18 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.47 |
| Envista Holdings (NVST) | United States | $3.441B | 13.09 |
| QuidelOrtho (QDEL) | United States | $2.654B | 9.63 |
| Green Thumb Industries (GTBIF) | United States | $2.482B | 78.67 |
| ICU Medical (ICUI) | United States | $2.303B | 17.19 |
| TG Therapeutics (TGTX) | United States | $2.150B | 695.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.906B | 0.00 |
| Owens & Minor (OMI) | United States | $1.848B | 17.74 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.617B | 0.00 |
| InMode (INMD) | Israel | $1.429B | 7.40 |
| LeMaitre Vascular (LMAT) | United States | $1.414B | 46.66 |
| National Vision Holdings (EYE) | United States | $1.399B | 43.58 |
| AdaptHealth (AHCO) | United States | $1.273B | 9.58 |
| Warby Parker (WRBY) | United States | $1.254B | 0.00 |
| AtriCure (ATRC) | United States | $1.094B | 0.00 |
| MacroGenics (MGNX) | United States | $0.899B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.872B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.764B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.686B | 14.82 |
| Cresco Labs (CRLBF) | United States | $0.674B | 0.00 |
| Evolus (EOLS) | United States | $0.664B | 0.00 |
| Jin Medical (ZJYL) | China | $0.608B | 0.00 |
| Quanterix (QTRX) | United States | $0.596B | 0.00 |
| Valneva SE (VALN) | France | $0.526B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.504B | 10.91 |
| PetIQ (PETQ) | United States | $0.480B | 17.93 |
| TerrAscend (TSNDF) | Canada | $0.462B | 0.00 |
| ZimVie (ZIMV) | United States | $0.421B | 25.80 |
| Biote (BTMD) | United States | $0.416B | 3.96 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.66 |
| Surmodics (SRDX) | United States | $0.373B | 40.26 |
| Aurora Cannabis (ACB) | Canada | $0.366B | 0.00 |
| Zynex (ZYXI) | United States | $0.352B | 40.52 |
| Viemed Healthcare (VMD) | United States | $0.310B | 30.81 |
| Cerus (CERS) | United States | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.266B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 14.73 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
| Omeros (OMER) | United States | $0.177B | 0.00 |
| Veru (VERU) | United States | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| High Tide (HITI) | Canada | $0.161B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.141B | 70.99 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| InterCure (INCR) | Israel | $0.120B | 20.31 |
| Fonar (FONR) | United States | $0.107B | 9.16 |
| MariMed (MRMD) | United States | $0.100B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
| Safety Shot (SHOT) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| Chimerix (CMRX) | United States | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.59 |
| Apyx Medical (APYX) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.95 |
| Bright Green (BGXX) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 74.09 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |